Literature DB >> 36104517

Diagnostic and Prognostic Value of Deregulated Circulating Long Non-coding RNA TUG1 in Elderly Patients with Severe Pneumonia.

Kai Gong1, Jiao Xu1, Jianlei Tang2.   

Abstract

To investigate the expression pattern of long non-coding RNA TUG1 in elderly patients with severe community-acquired pneumonia (sCAP) and evaluate its diagnostic and prognostic value for sCAP. Serum TUG1 levels were detected in 130 sCAP patients and 122 healthy volunteers via qRT-PCR method. The receiver operating characteristic (ROC) curve and k-M plot were drawn for the diagnostic and prognostic value evaluation. A diminished trend of TUG1 was detected in the serum of sCAP cases, and negatively correlated with the concentration of TNF-α, CRP, suPAR and sTREM-1. Among the 130 cases, 30 cases died from sCAP within 30 days after admission. Serum TUG1 had the diagnostic value for 30-day mortality prediction with the AUC of 0.823. In the non-survival group, more cases had old age, high CURB score and PSI score. K-M plot demonstrated that cases with low TUG1 levels showed poor survival than those carrying high TUG1 levels. Serum TUG1 was an independent risk factor for death in elderly patients with sCAP within 30 days after admission. Serum TUG1 was at low expression in sCAP patients, and it had the predictive value for the clinical prognosis of elderly sCAP patients.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Inflammation; Severe community-acquired pneumonia; Survival; TUG1

Year:  2022        PMID: 36104517     DOI: 10.1007/s10753-022-01735-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  25 in total

1.  Effect of lncRNA MALAT1 expression on survival status of elderly patients with severe pneumonia.

Authors:  L-P Yan; Z-B Liu; M Wu; Y-P Ge; Q Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

2.  Comprehensive Analysis of lncRNA and mRNA Expression Profiles in Lung Cancer.

Authors:  Ran Chen; Wen-Xing Li; Yan Sun; Yong Duan; Qing Li; Ai-Xing Zhang; Jia-Lun Hu; Yu-Ming Wang; Yue-Dong Gao
Journal:  Clin Lab       Date:  2017-02-01       Impact factor: 1.138

3.  lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206.

Authors:  H-L Cao; Z-J Liu; P-L Huang; Y-L Yue; J-N Xi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-02       Impact factor: 3.507

4.  LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1.

Authors:  Yan Li; Wenqing Sun; Honghong Pan; Jiali Yuan; Qi Xu; Tiantian Xu; Ping Li; Demin Cheng; Yi Liu; Chunhui Ni
Journal:  Ecotoxicol Environ Saf       Date:  2021-02-16       Impact factor: 6.291

5.  A preliminary analysis of LncRNA biomarkers for schizophrenia.

Authors:  Jiao Jia; Xiaofei Liu; Lina Ma; Yong Xu; Yan Ren
Journal:  Epigenomics       Date:  2021-09-16       Impact factor: 4.778

6.  Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial.

Authors:  Ping Wang; Yuanlin Song; Zhi Liu; Hui Wang; Wenke Zheng; Si Liu; Zhiqiao Feng; Jingbo Zhai; Chen Yao; Ming Ren; Chunxue Bai; Hongcai Shang
Journal:  Trials       Date:  2016-03-17       Impact factor: 2.279

7.  Long noncoding RNA TUG1 inhibits osteogenesis of bone marrow mesenchymal stem cells via Smad5 after irradiation.

Authors:  Weiwei Zhang; Li Chen; Jiang Wu; Jiuxuan Li; Xiaomei Zhang; Yang Xiang; Fengjie Li; Chun Wu; Lixin Xiang; Qian Ran; Zhongjun Li
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

8.  Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis.

Authors:  Kai Huang; Catherine Wang; Christen Vagts; Vanitha Raguveer; Patricia W Finn; David L Perkins
Journal:  PLoS One       Date:  2022-01-10       Impact factor: 3.240

9.  Upregulated expression of long non-coding RNA MEG3 serves as a prognostic biomarker in severe pneumonia children and its regulatory mechanism.

Authors:  Jie Guo; Ning Zhang; Guozhi Liu; Aimei Zhang; Xin Liu; Jie Zheng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 10.  The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases.

Authors:  Ying Huang
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.